With regard to the genetic profiling, we found one AD patient with a known pathogenic PSEN1 (PSEN1 p.C263F) mutation and one AD patient with the Belgian ABCA7 founder mutation (ABCA7 p.E709Afs*85) [54, 55]. This evidence concerns the gene ABCA7 and Alzheimer disease.